Covered recipient · General Payments record
KRYSTAL BALAGOT RIVERA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2023–2024
$436.39
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $338.64 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $79.61 | 4 |
| Novo Nordisk AS | $72.02 | 4 |
| DEXCOM, INC. | $49.09 | 1 |
| Tandem Diabetes Care, Inc. | $46.63 | 2 |
| CeQur Corporation | $23.44 | 1 |
| Exact Sciences Corporation | $18.13 | 1 |
| PFIZER INC. | $16.99 | 1 |
| SANOFI-AVENTIS U.S. LLC | $16.58 | 1 |
| Insulet Corporation | $16.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CeQur Corporation | $23.44 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126844466 | CMS |
| Dexcom, Inc. | $49.09 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153315042 | CMS |
| Exact Sciences Corporation | $18.13 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114429803 | CMS |
| Insulet Corporation | $16.15 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116792152 | CMS |
| Lilly USA, LLC | $18.10 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135120367 | CMS |
| Lilly USA, LLC | $21.30 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135120369 | CMS |
| Lilly USA, LLC | $17.21 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135141869 | CMS |
| Lilly USA, LLC | $23.00 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135137480 | CMS |
| Novo Nordisk Inc | $18.40 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097771013 | CMS |
| Novo Nordisk Inc | $17.99 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096764806 | CMS |
| Novo Nordisk Inc | $18.37 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097163534 | CMS |
| Novo Nordisk Inc | $17.26 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097073776 | CMS |
| PFIZER INC. | $16.99 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033247 | CMS |
| SANOFI-AVENTIS U.S. LLC | $16.58 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139975973 | CMS |
| Tandem Diabetes Care, Inc. | $15.68 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138738829 | CMS |
| Tandem Diabetes Care, Inc. | $30.95 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138738809 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.